drugset / Trial / NCT03740919

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes

NCT03740919

Phase 3 Completed 751 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The reason for this study is to compare the study drug LY900014 to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).

Timeline

Start
2019-04-07
Primary completion
2021-07-02
Completion
2021-07-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Lispro Protein / enzyme biologic Subcutaneous
Comparator insulin degludec Protein / enzyme biologic Subcutaneous
Comparator insulin glargine Protein / enzyme biologic Subcutaneous